Cargando…
Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis
BACKGROUND/AIMS: A growing body of evidence has suggested that thiazolidinediones (TZDs) potentially reduce the risk of colorectal cancer (CRC). This study aimed to evaluate the effect of TZDs on CRC risk in patients with diabetes mellitus (DM). PATIENTS AND METHODS: A systematic search of electroni...
Autores principales: | Liu, Yang, Jin, Piao-Piao, Sun, Xue-Cheng, Hu, Ting-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900477/ https://www.ncbi.nlm.nih.gov/pubmed/29637913 http://dx.doi.org/10.4103/sjg.SJG_295_17 |
Ejemplares similares
-
Thiazolidinediones versus metformin on improving abnormal liver enzymes in patients with type 2 diabetes mellitus: a meta-analysis
por: Xu, Chunmei, et al.
Publicado: (2018) -
Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
por: Lin, Chu, et al.
Publicado: (2023) -
Efficacy and Safety of Novel Thiazolidinedione Rivoglitazone in Type-2 Diabetes a Meta-Analysis
por: Dutta, Deep, et al.
Publicado: (2023) -
Adiponectin gene polymorphisms and risk of gestational diabetes mellitus: A meta-analysis
por: Huang, Lin-Ting, et al.
Publicado: (2019) -
Water exchange versus air insufflation for colonoscopy: A meta-analysis
por: Liu, Yang, et al.
Publicado: (2018)